Market research
PMA Ming Shing Group Holdings Limited Ordinary Shares
NASDAQ USD Industrials
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 202M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- Not available
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Industrials
- Industry
- Engineering & Construction
- ISIN
- KYG614401068
- Market cap
- 202M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- Not available
About
About Ming Shing Group Holdings Limited Ordinary Shares
PMA Graphene Technology Group Inc., through its subsidiaries, engages in wet trades works in Hong Kong. Its works include plastering, tile laying, brick laying, floor screeding, and marble works, as well as small-scale fitting out services, such as renovation works. The company also trades in wines and spirits. It primarily serves construction contractors in public and private sectors. The company was formerly known as Ming Shing Group Holdings Limited and changed its name to PMA Graphene Technology Group Inc. in August 2026. The company was incorporated in 2022 and is based in Cheung Sha Wan, Hong Kong.
Research context
Ming Shing Group Holdings Limited Ordinary Shares appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Industrials
- Industry
- Engineering & Construction
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
0 comments
Sign in to join the PMA discussion.
No comments yet
Start a focused discussion about PMA.